Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
NCT02858323
Blood Platelet Disorders, Cytopenia
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT00759980
Thrombocytopenia (low platelet count) is common in the neonatal intensive care unit. Commonly, the decision of when to transfuse platelets is based on platelet number. Recently, Christensen et al (2006) proposed using transfusion guidelines based on platelet mass rather than platelet number. By using platelet size as a guide of when to give platelets, we may be able to decrease the amount platelet transfusions needed.
This study is investigating using platelet size rather than platelet number as a guideline for transfusing platelets in infants who are hospitalized in a NICU (neonatal intensive care unit). After obtaining parental informed consent, thrombocytopenic infants will be randomized to one of two groups. 1: Transfusion based on platelet number; 2: transfusion based on a combination of platelet number and platelet mass. In each group the decision to transfuse platelets will be made using a slightly different, yet strict set of transfusion rules.
The objective is to determine the feasibility, rate of bleeding complications and compliance of transfusing neonates based on platelet mass rather than platelet number.
The investigators hypothesize that transfusing platelets based on platelet mass will not increase bleeding complications and will reduce the number of transfusions in thrombocytopenic neonates.
Looking for future studies?
Notify MeUp to 12 month
All sexes
Observational
Christiana Care Health System, Newark, Delaware, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: During NICU hospitalization
Time frame: While the infant is thrombocytopenic
Time frame: During NICU hospitalization
Christiana Care Health Services
Other
Transfusing Neonates Based on Platelet Mass in the Neonatal Intensive Care Unit: A Randomized Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02858323
Blood Platelet Disorders, Cytopenia
Bethesda, Maryland, United States
View Trial DetailsNCT03515447
Blood Platelet Disorders, Cytopenia
Nantes, France
View Trial DetailsNCT06187831
Bleeding, Blood Platelet Disorders
Lund, Lunds Universitet, Sweden
View Trial DetailsNCT04673266
Blood Platelet Disorders, Cytopenia
Basking Ridge, New Jersey, United States
View Trial Details